David J. Mazzo, Ph.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Lisata Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get LSTA alertsAbout David J. Mazzo, Ph.D.
David J. Mazzo, Ph.D. is recorded as CEO at Lisata Therapeutics, Inc. (LSTA) since September 15, 2022. Lisata Therapeutics, Inc. reported in an 8-K filed September 17, 2026 that David J. Mazzo, Ph.D. resigned as President, effective September 17, 2026. Lisata Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lisata Therapeutics, Inc. includes David J. Mazzo (CEO and Board Member), Gregory Brown (Chairman), Gregory Brown, M.D. (Chairman) and 7 others.
“Immediately prior to such appointment, David J. Mazzo, Ph.D. resigned solely from the office of President, but he retained his position as Chief Executive Officer of the Company.”
Affiliation history
-
Current
2022-09-15–present
Company network
Leadership on record at Lisata Therapeutics, Inc.
- David J. Mazzo CEO, Board Member
- Gregory Brown Chairman
- Gregory Brown, M.D. Chairman
- Dr. Josh Lehrer COO
- Josh Lehrer COO
- Josh Lehrer, M.D., M.Phil., FACC COO
- Tariq Imam General Counsel
- James Nisco Chief Accounting Officer
- Anne Whitaker Board Member
- CLASS I Board Member